サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1472376

ダイレクトプライマリケア市場：タイプ別世界の機会分析と産業予測、2023年～2032年

Direct Primary Care Market By Type (Clinical Services, Laboratory Services, Consultative Services, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日
ページ情報
英文 320 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ダイレクトプライマリケア市場：タイプ別世界の機会分析と産業予測、2023年～2032年
出版日: 2024年03月01日
発行: Allied Market Research
ページ情報: 英文 320 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のダイレクトプライマリケア市場は、2023年から2032年までのCAGR4.3%で、2022年の557億6,120万米ドルから成長し、2032年には823億9,520万米ドルに達すると予測されます。

Direct Primary Care Market-IMG1

ダイレクトプライマリケア（DPC）モデルとは、患者・消費者が、決められたプライマリケアサービスに対して、定期的な支払いの形で医師や診療所に直接支払う診療・支払いモデルです。DPC診療所では、幅広いプライマリ・ケアと医療管理サービスを利用する代わりに、契約に基づいて患者に月定額または年額料金を請求します。DPC診療の枠組みには、患者／消費者と直接契約し、月払いまたは年払いの料金を請求する診療モデルも含まれ、プライマリ・ケアサービスに第三者保険が適用される従来のシステムに取って代わる役割を果たします。このような定期的な支払いは、従来のフィー・フォー・サービス医療よりも充実したサービスを患者に提供します。このようなサービスには、高度な通信技術を利用したかかりつけ医へのリアルタイムアクセス、長時間の訪問診療、場合によっては在宅診療、高度に個別化・調整された包括的なケア管理などが含まれます。米国家庭医学会（AAFP）は、DPC診療を含むあらゆる倫理的なヘルスケア提供システムモデルにおいて、医師と患者がそれぞれヘルスケアを提供し、受けることを選択することを支持しています。

世界的に老年人口が増加の一途をたどっていることから、プライマリ・ケアを直接提供する業界には大きな可能性があります。世界保健機関（WHO）によると、60歳以上の世界人口は2050年までに21億人に達すると予測されています。高齢者はヘルスケアのニーズが高く、多くの併存疾患に対して連携したケアを受けなければならないです。プライマリ・ケア医は、この層にとって最初の窓口です。彼らは予防医療を提供し、慢性疾患を管理し、円滑なケア移行を促進します。プライマリ・ケア医は高齢者疾患の治療経験が豊富で、全般的な健康状態を重視するため、高齢者のケアに適しています。これが市場拡大を促す基本要因となっています。

DPCは、定期検診、予防医療、軽度の急性疾患などの基本的なプライマリケアサービスをカバーします。DPCに加入していない専門医療や入院、その他の医療サービスについては、別途保険に加入するか、自己負担する必要があります。DPCに加入している患者は、1人のプライマリ・ケア提供者にしかアクセスできないか、DPC診療所内の少数の提供者グループにしかアクセスできない可能性があります。このような医療提供者の選択肢の少なさは、選択肢があることを好む患者や、DPCネットワーク外の専門医による治療を必要とする患者にとって不利になる可能性があります。こうした要因が市場の成長を抑制すると予想されます。

DPCモデルでは、プライマリ・ケアへのアクセスが向上し、予約時間の延長や医師によるきめ細かな対応が患者に提供されることが多いです。これは、患者の満足度とロイヤルティの向上につながります。DPC診療所では、保険仲介業者の必要性を排除し、管理上のオーバーヘッドを削減することで、患者により手頃なヘルスケアの選択肢を提供することができます。定額制の料金体系により、患者は医療費の予算をより予測しやすくなります。DPCにより、医師は複雑な保険請求手続きを行う必要がなくなり、より多くの時間を患者のケアに費やすことができます。これにより、医師の燃え尽き率が減少し、仕事に対する満足度が向上します。DPCモデルは、医師が患者集団の特定のニーズを満たすためにサービスを革新し、調整するための柔軟性を提供します。これには、遠隔医療を取り入れたり、診療時間を延長したり、慢性疾患管理プログラムを実施したりすることが含まれます。

本レポートで紹介する主なプレーヤーは、One Medical、Oak Street Health、Paladina Health、Forward Health、Crossover Health、EverMed、Plum Health、Nextera Healthcare、Boston Direct Health、PeakMedなどです。市場参入企業は、提携や買収などの戦略を駆使して、この競争市場で優位に立とうと努力を続けています。

利害関係者にとっての主なメリット

  • 当レポートでは、2022年から2032年にかけてのダイレクトプライマリケア市場分析の市場セグメント、現在の動向、推定・動向、ダイナミクスを定量的に分析し、一般的なダイレクトプライマリケア市場の機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの潜在力を明らかにします。
  • ダイレクトプライマリケア市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
  • 本レポートには、地域および世界のダイレクトプライマリケア市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートのカスタマイズが可能です（別途費用と期間がかかりますので、詳細は営業担当者にお問い合わせください）。

  • 投資機会
  • 製品ベンチマーク／製品仕様と用途
  • サプライチェーン分析とベンダーマージン
  • 地域別新規参入企業
  • 技術動向分析
  • ディストリビューターのマージン分析
  • 製品別/セグメント別プレーヤーシェア分析
  • 規制ガイドライン
  • 顧客の関心に応じた追加企業プロファイル
  • 国別または地域別追加分析-市場規模と予測
  • クリスクロスセグメント分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 輸出入分析/データ
  • 世界/地域/国別レベルでのプレーヤーの市場シェア分析
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 平均販売価格
  • 市場シェア分析
  • ブランドシェア分析
  • 貿易データ分析
  • 製品消費
  • バリューチェーン分析
  • 主要規制分析
  • 特許情勢
  • 規制ガイドライン
  • 償還シナリオ

第4章 ダイレクトプライマリケア市場：タイプ別

  • 概要
  • 臨床サービス
  • 検査サービス
  • コンサルティングサービス
  • その他

第5章 ダイレクトプライマリケア市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他

第6章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第7章 企業プロファイル

  • One Medical
  • Oak Street Health
  • Paladina Health
  • Forward Health
  • Crossover Health
  • EverMed
  • Plum Health
  • Nextera Healthcare
  • Boston Direct Health
  • PeakMed
図表

LIST OF TABLES

  • TABLE 01. GLOBAL DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. DIRECT PRIMARY CARE MARKET FOR CLINICAL SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. DIRECT PRIMARY CARE MARKET FOR LABORATORY SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. DIRECT PRIMARY CARE MARKET FOR CONSULTATIVE SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. DIRECT PRIMARY CARE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. DIRECT PRIMARY CARE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. NORTH AMERICA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 08. NORTH AMERICA DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 09. U.S. DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. CANADA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 11. MEXICO DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 12. EUROPE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. EUROPE DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 14. GERMANY DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. UK DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. FRANCE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. SPAIN DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. ITALY DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. REST OF EUROPE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. ASIA-PACIFIC DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. ASIA-PACIFIC DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 22. CHINA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. JAPAN DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. INDIA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. SOUTH KOREA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. AUSTRALIA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. REST OF EUROPE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. LAMEA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. LAMEA DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. BRAZIL DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. SAUDI ARABIA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. UNITED ARAB EMIRATES DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. SOUTH AFRICA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. REST OF LAMEA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. ONE MEDICAL: KEY EXECUTIVES
  • TABLE 36. ONE MEDICAL: COMPANY SNAPSHOT
  • TABLE 37. ONE MEDICAL: PRODUCT SEGMENTS
  • TABLE 38. ONE MEDICAL: SERVICE SEGMENTS
  • TABLE 39. ONE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 40. ONE MEDICAL: KEY STRATERGIES
  • TABLE 41. OAK STREET HEALTH: KEY EXECUTIVES
  • TABLE 42. OAK STREET HEALTH: COMPANY SNAPSHOT
  • TABLE 43. OAK STREET HEALTH: PRODUCT SEGMENTS
  • TABLE 44. OAK STREET HEALTH: SERVICE SEGMENTS
  • TABLE 45. OAK STREET HEALTH: PRODUCT PORTFOLIO
  • TABLE 46. OAK STREET HEALTH: KEY STRATERGIES
  • TABLE 47. PALADINA HEALTH: KEY EXECUTIVES
  • TABLE 48. PALADINA HEALTH: COMPANY SNAPSHOT
  • TABLE 49. PALADINA HEALTH: PRODUCT SEGMENTS
  • TABLE 50. PALADINA HEALTH: SERVICE SEGMENTS
  • TABLE 51. PALADINA HEALTH: PRODUCT PORTFOLIO
  • TABLE 52. PALADINA HEALTH: KEY STRATERGIES
  • TABLE 53. FORWARD HEALTH: KEY EXECUTIVES
  • TABLE 54. FORWARD HEALTH: COMPANY SNAPSHOT
  • TABLE 55. FORWARD HEALTH: PRODUCT SEGMENTS
  • TABLE 56. FORWARD HEALTH: SERVICE SEGMENTS
  • TABLE 57. FORWARD HEALTH: PRODUCT PORTFOLIO
  • TABLE 58. FORWARD HEALTH: KEY STRATERGIES
  • TABLE 59. CROSSOVER HEALTH: KEY EXECUTIVES
  • TABLE 60. CROSSOVER HEALTH: COMPANY SNAPSHOT
  • TABLE 61. CROSSOVER HEALTH: PRODUCT SEGMENTS
  • TABLE 62. CROSSOVER HEALTH: SERVICE SEGMENTS
  • TABLE 63. CROSSOVER HEALTH: PRODUCT PORTFOLIO
  • TABLE 64. CROSSOVER HEALTH: KEY STRATERGIES
  • TABLE 65. EVERMED: KEY EXECUTIVES
  • TABLE 66. EVERMED: COMPANY SNAPSHOT
  • TABLE 67. EVERMED: PRODUCT SEGMENTS
  • TABLE 68. EVERMED: SERVICE SEGMENTS
  • TABLE 69. EVERMED: PRODUCT PORTFOLIO
  • TABLE 70. EVERMED: KEY STRATERGIES
  • TABLE 71. PLUM HEALTH: KEY EXECUTIVES
  • TABLE 72. PLUM HEALTH: COMPANY SNAPSHOT
  • TABLE 73. PLUM HEALTH: PRODUCT SEGMENTS
  • TABLE 74. PLUM HEALTH: SERVICE SEGMENTS
  • TABLE 75. PLUM HEALTH: PRODUCT PORTFOLIO
  • TABLE 76. PLUM HEALTH: KEY STRATERGIES
  • TABLE 77. NEXTERA HEALTHCARE: KEY EXECUTIVES
  • TABLE 78. NEXTERA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 79. NEXTERA HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 80. NEXTERA HEALTHCARE: SERVICE SEGMENTS
  • TABLE 81. NEXTERA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 82. NEXTERA HEALTHCARE: KEY STRATERGIES
  • TABLE 83. BOSTON DIRECT HEALTH: KEY EXECUTIVES
  • TABLE 84. BOSTON DIRECT HEALTH: COMPANY SNAPSHOT
  • TABLE 85. BOSTON DIRECT HEALTH: PRODUCT SEGMENTS
  • TABLE 86. BOSTON DIRECT HEALTH: SERVICE SEGMENTS
  • TABLE 87. BOSTON DIRECT HEALTH: PRODUCT PORTFOLIO
  • TABLE 88. BOSTON DIRECT HEALTH: KEY STRATERGIES
  • TABLE 89. PEAKMED: KEY EXECUTIVES
  • TABLE 90. PEAKMED: COMPANY SNAPSHOT
  • TABLE 91. PEAKMED: PRODUCT SEGMENTS
  • TABLE 92. PEAKMED: SERVICE SEGMENTS
  • TABLE 93. PEAKMED: PRODUCT PORTFOLIO
  • TABLE 94. PEAKMED: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. DIRECT PRIMARY CARE MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF DIRECT PRIMARY CARE MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN DIRECT PRIMARY CARE MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN DIRECT PRIMARY CARE MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL DIRECT PRIMARY CARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. IMPACT OF KEY REGULATION: DIRECT PRIMARY CARE MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. DIRECT PRIMARY CARE MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR CLINICAL SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR LABORATORY SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR CONSULTATIVE SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. DIRECT PRIMARY CARE MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 20. U.S. DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 21. CANADA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. MEXICO DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. GERMANY DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. UK DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. FRANCE DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. SPAIN DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. ITALY DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. REST OF EUROPE DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. CHINA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. JAPAN DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. INDIA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SOUTH KOREA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. AUSTRALIA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. BRAZIL DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SAUDI ARABIA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. UNITED ARAB EMIRATES DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH AFRICA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF LAMEA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: DIRECT PRIMARY CARE MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2022
目次
Product Code: A304539

The global direct primary care market is anticipated to reach $ 82,395.2 million by 2032, growing from $55,761.2 million in 2022 at a CAGR of 4.3% from 2023 to 2032.

Direct Primary Care Market - IMG1

The direct primary care (DPC) model is a practice and payment model where patients/consumers pay their physician or practice directly in the form of periodic payments for a defined set of primary care services. DPC practices charge patients a flat monthly or annual fee, under terms of a contract, in exchange for access to a broad range of primary care and medical administrative services. The DPC practice framework includes any practice model structured around direct contracting with patients/consumers for monthly or annual fees, which serve to replace the traditional system of third-party insurance coverage for primary care services. These periodic payments provide patients enhanced services over traditional fee-for-service medicine. Such services may include real-time access via advanced communication technology to their personal physician, extended visits, in some cases home-based medical visits, and highly personalized, coordinated, and comprehensive care administration. The American Academy of Family Physicians (AAFP) supports the physician and patient choice to, respectively, provide and receive healthcare in any ethical healthcare delivery system model, including the DPC practice setting.

The constantly rising geriatric population worldwide creates enormous prospects in the direct primary care industry. According to the World Health Organization (WHO), the global population aged 60 and above is predicted to reach 2.1 billion by 2050. Elderly patients have higher healthcare needs and must receive coordinated care for many comorbidities. Primary care physicians are the first point of contact for this demographic. They offer preventive care, manage chronic conditions, and facilitate smooth care transitions. Primary care physicians are well-suited to caring for the elderly due to their experience treating geriatric illnesses and emphasis on general well-being. This is a fundamental driver driving market expansion.

DPC covers basic primary care services, such as routine check-ups, preventive care, and minor acute illnesses. Patients may still need to purchase separate insurance or pay out-of-pocket for specialty care, hospitalizations, and other medical services not included in their DPC membership. Patients enrolled in DPC may have access to only one primary care provider or a small group of providers within the DPC practice. This lack of choice in providers could be a disadvantage for patients who prefer to have options or who need care from specialists outside the DPC network. These factors are anticipated to restrain the market growth.

DPC models offer patients with increased access to primary care services, often with extended appointment times and more personalized attention from physicians. This leads to improved patient satisfaction and loyalty. By eliminating the need for insurance middlemen and reducing administrative overhead, DPC practices can offer more affordable healthcare options for patients. The flat fee structure allows patients to budget for their healthcare expenses more predictably. DPC eliminates the need for physicians to navigate complex insurance billing processes, allowing them to spend more time delivering patient care. This can lead to reduced burnout rates among physicians and improved job satisfaction. DPC models provide flexibility for physicians to innovate and tailor services to meet the specific needs of their patient population. This could include incorporating telemedicine, offering extended hours, or implementing chronic disease management programs.

The key players profiled in this report include One Medical, Oak Street Health, Paladina Health, Forward Health, Crossover Health, EverMed, Plum Health, Nextera Healthcare, Boston Direct Health, and PeakMed. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the direct primary care market analysis from 2022 to 2032 to identify the prevailing direct primary care market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the direct primary care market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global direct primary care market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Investment Opportunities
  • Product Benchmarking / Product specification and applications
  • Supply Chain Analysis & Vendor Margins
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Distributor margin Analysis
  • Market share analysis of players by products/segments
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Type

  • Clinical Services
  • Laboratory Services
  • Consultative Services
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Europe
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • One Medical
    • Oak Street Health
    • Paladina Health
    • Forward Health
    • Crossover Health
    • EverMed
    • Plum Health
    • Nextera Healthcare
    • Boston Direct Health
    • PeakMed

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Key Regulation Analysis
  • 3.12. Patent Landscape
  • 3.13. Regulatory Guidelines
  • 3.14. Reimbursement Scenario

CHAPTER 4: DIRECT PRIMARY CARE MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Clinical Services
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Laboratory Services
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Consultative Services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: DIRECT PRIMARY CARE MARKET, BY REGION

  • 5.1. Overview
    • 5.1.1. Market size and forecast By Region
  • 5.2. North America
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by Type
    • 5.2.3. Market size and forecast, by country
      • 5.2.3.1. U.S.
      • 5.2.3.1.1. Market size and forecast, by Type
      • 5.2.3.2. Canada
      • 5.2.3.2.1. Market size and forecast, by Type
      • 5.2.3.3. Mexico
      • 5.2.3.3.1. Market size and forecast, by Type
  • 5.3. Europe
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by Type
    • 5.3.3. Market size and forecast, by country
      • 5.3.3.1. Germany
      • 5.3.3.1.1. Market size and forecast, by Type
      • 5.3.3.2. UK
      • 5.3.3.2.1. Market size and forecast, by Type
      • 5.3.3.3. France
      • 5.3.3.3.1. Market size and forecast, by Type
      • 5.3.3.4. Spain
      • 5.3.3.4.1. Market size and forecast, by Type
      • 5.3.3.5. Italy
      • 5.3.3.5.1. Market size and forecast, by Type
      • 5.3.3.6. Rest of Europe
      • 5.3.3.6.1. Market size and forecast, by Type
  • 5.4. Asia-Pacific
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by Type
    • 5.4.3. Market size and forecast, by country
      • 5.4.3.1. China
      • 5.4.3.1.1. Market size and forecast, by Type
      • 5.4.3.2. Japan
      • 5.4.3.2.1. Market size and forecast, by Type
      • 5.4.3.3. India
      • 5.4.3.3.1. Market size and forecast, by Type
      • 5.4.3.4. South Korea
      • 5.4.3.4.1. Market size and forecast, by Type
      • 5.4.3.5. Australia
      • 5.4.3.5.1. Market size and forecast, by Type
      • 5.4.3.6. Rest of Europe
      • 5.4.3.6.1. Market size and forecast, by Type
  • 5.5. LAMEA
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by Type
    • 5.5.3. Market size and forecast, by country
      • 5.5.3.1. Brazil
      • 5.5.3.1.1. Market size and forecast, by Type
      • 5.5.3.2. Saudi Arabia
      • 5.5.3.2.1. Market size and forecast, by Type
      • 5.5.3.3. United Arab Emirates
      • 5.5.3.3.1. Market size and forecast, by Type
      • 5.5.3.4. South Africa
      • 5.5.3.4.1. Market size and forecast, by Type
      • 5.5.3.5. Rest of LAMEA
      • 5.5.3.5.1. Market size and forecast, by Type

CHAPTER 6: COMPETITIVE LANDSCAPE

  • 6.1. Introduction
  • 6.2. Top winning strategies
  • 6.3. Product mapping of top 10 player
  • 6.4. Competitive dashboard
  • 6.5. Competitive heatmap
  • 6.6. Top player positioning, 2022

CHAPTER 7: COMPANY PROFILES

  • 7.1. One Medical
    • 7.1.1. Company overview
    • 7.1.2. Key executives
    • 7.1.3. Company snapshot
    • 7.1.4. Operating business segments
    • 7.1.5. Product portfolio
    • 7.1.6. Business performance
    • 7.1.7. Key strategic moves and developments
  • 7.2. Oak Street Health
    • 7.2.1. Company overview
    • 7.2.2. Key executives
    • 7.2.3. Company snapshot
    • 7.2.4. Operating business segments
    • 7.2.5. Product portfolio
    • 7.2.6. Business performance
    • 7.2.7. Key strategic moves and developments
  • 7.3. Paladina Health
    • 7.3.1. Company overview
    • 7.3.2. Key executives
    • 7.3.3. Company snapshot
    • 7.3.4. Operating business segments
    • 7.3.5. Product portfolio
    • 7.3.6. Business performance
    • 7.3.7. Key strategic moves and developments
  • 7.4. Forward Health
    • 7.4.1. Company overview
    • 7.4.2. Key executives
    • 7.4.3. Company snapshot
    • 7.4.4. Operating business segments
    • 7.4.5. Product portfolio
    • 7.4.6. Business performance
    • 7.4.7. Key strategic moves and developments
  • 7.5. Crossover Health
    • 7.5.1. Company overview
    • 7.5.2. Key executives
    • 7.5.3. Company snapshot
    • 7.5.4. Operating business segments
    • 7.5.5. Product portfolio
    • 7.5.6. Business performance
    • 7.5.7. Key strategic moves and developments
  • 7.6. EverMed
    • 7.6.1. Company overview
    • 7.6.2. Key executives
    • 7.6.3. Company snapshot
    • 7.6.4. Operating business segments
    • 7.6.5. Product portfolio
    • 7.6.6. Business performance
    • 7.6.7. Key strategic moves and developments
  • 7.7. Plum Health
    • 7.7.1. Company overview
    • 7.7.2. Key executives
    • 7.7.3. Company snapshot
    • 7.7.4. Operating business segments
    • 7.7.5. Product portfolio
    • 7.7.6. Business performance
    • 7.7.7. Key strategic moves and developments
  • 7.8. Nextera Healthcare
    • 7.8.1. Company overview
    • 7.8.2. Key executives
    • 7.8.3. Company snapshot
    • 7.8.4. Operating business segments
    • 7.8.5. Product portfolio
    • 7.8.6. Business performance
    • 7.8.7. Key strategic moves and developments
  • 7.9. Boston Direct Health
    • 7.9.1. Company overview
    • 7.9.2. Key executives
    • 7.9.3. Company snapshot
    • 7.9.4. Operating business segments
    • 7.9.5. Product portfolio
    • 7.9.6. Business performance
    • 7.9.7. Key strategic moves and developments
  • 7.10. PeakMed
    • 7.10.1. Company overview
    • 7.10.2. Key executives
    • 7.10.3. Company snapshot
    • 7.10.4. Operating business segments
    • 7.10.5. Product portfolio
    • 7.10.6. Business performance
    • 7.10.7. Key strategic moves and developments